Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081661 | SCV000113592 | benign | not specified | 2012-08-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000081661 | SCV000169871 | benign | not specified | 2013-09-16 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genetic Services Laboratory, |
RCV000081661 | SCV000195490 | benign | not specified | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000429313 | SCV000511120 | benign | not provided | 2017-01-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000387354 | SCV000555853 | benign | Mowat-Wilson syndrome | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316258 | SCV000851380 | benign | Inborn genetic diseases | 2022-02-25 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000387354 | SCV002045680 | benign | Mowat-Wilson syndrome | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000387354 | SCV002807453 | likely benign | Mowat-Wilson syndrome | 2021-07-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000429313 | SCV004011194 | likely benign | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | ZEB2: BP4, BS1 |
Breakthrough Genomics, |
RCV000429313 | SCV005255787 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV000429313 | SCV001977974 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000429313 | SCV001980630 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004752742 | SCV005352770 | benign | ZEB2-related disorder | 2024-06-03 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |